Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, England.
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, England.
Chest. 2023 Sep;164(3):700-716. doi: 10.1016/j.chest.2023.03.024. Epub 2023 Mar 24.
Microvascular abnormalities and impaired gas transfer have been observed in patients with COVID-19. The progression of pulmonary changes in these patients remains unclear.
Do patients hospitalized with COVID-19 without evidence of architectural distortion on structural imaging exhibit longitudinal improvements in lung function measured by using H and Xe MRI between 6 and 52 weeks following hospitalization?
Patients who were hospitalized with COVID-19 pneumonia underwent a pulmonary H and Xe MRI protocol at 6, 12, 25, and 51 weeks following hospital admission in a prospective cohort study between November 2020 and February 2022. The imaging protocol was as follows: H ultra-short echo time, contrast-enhanced lung perfusion, Xe ventilation, Xe diffusion-weighted, and Xe spectroscopic imaging of gas exchange.
Nine patients were recruited (age 57 ± 14 [median ± interquartile range] years; six of nine patients were male). Patients underwent MRI at 6 (n = 9), 12 (n = 9), 25 (n = 6), and 51 (n = 8) weeks following hospital admission. Patients with signs of interstitial lung damage were excluded. At 6 weeks, patients exhibited impaired Xe gas transfer (RBC to membrane fraction), but lung microstructure was not increased (apparent diffusion coefficient and mean acinar airway dimensions). Minor ventilation abnormalities present in four patients were largely resolved in the 6- to 25-week period. At 12 weeks, all patients with lung perfusion data (n = 6) showed an increase in both pulmonary blood volume and flow compared with 6 weeks, although this was not statistically significant. At 12 weeks, significant improvements in Xe gas transfer were observed compared with 6-week examinations; however, Xe gas transfer remained abnormally low at weeks 12, 25, and 51.
Xe gas transfer was impaired up to 1 year following hospitalization in patients who were hospitalized with COVID-19 pneumonia, without evidence of architectural distortion on structural imaging, whereas lung ventilation was normal at 52 weeks.
在 COVID-19 患者中观察到微血管异常和气体转移受损。这些患者的肺部变化进展仍不清楚。
在结构性影像学无结构扭曲证据的 COVID-19 住院患者中,在住院后 6 至 52 周之间,使用 H 和 Xe MRI 测量的肺功能是否会出现纵向改善?
2020 年 11 月至 2022 年 2 月期间,在一项前瞻性队列研究中,患有 COVID-19 肺炎的住院患者在住院后 6、12、25 和 51 周时进行肺部 H 和 Xe MRI 方案。成像方案如下:H 超短回波时间、对比增强肺灌注、Xe 通气、Xe 弥散加权和 Xe 光谱成像的气体交换。
招募了 9 名患者(年龄 57 ± 14[中位数±四分位数范围]岁;9 名患者中有 6 名男性)。患者在住院后 6(n=9)、12(n=9)、25(n=6)和 51(n=8)周时进行了 MRI。排除有间质性肺损伤迹象的患者。在 6 周时,患者表现出 Xe 气体转移受损(RBC 至膜部分),但肺微观结构没有增加(表观扩散系数和平均腺泡气道尺寸)。4 名患者中存在的轻微通气异常在 6 至 25 周期间基本得到解决。在 12 周时,所有有肺灌注数据的患者(n=6)与 6 周时相比,肺血容量和流量均增加,尽管这没有统计学意义。在 12 周时,与 6 周检查相比,Xe 气体转移显著改善;然而,Xe 气体转移在 12、25 和 51 周时仍异常低。
在结构性影像学无结构扭曲证据的 COVID-19 住院肺炎患者中,住院后 1 年 Xe 气体转移受损,而肺通气在 52 周时正常。